Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/31/2007 | US7250407 For the treatment of disorders associated with dyslipoproteinemia, including cardiovascular disease, atherosclerosis, restenosis, hyperlipidemia, and endotoxemia septic shock |
07/31/2007 | US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier |
07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
07/31/2007 | US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
07/31/2007 | US7250172 Vaccine and compositions for the prevention and treatment of neisserial infections |
07/31/2007 | US7250168 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome |
07/31/2007 | CA2398353C Anticancer compound and enantiomer separation method useful for synthesizing said compound |
07/31/2007 | CA2258683C Oral composition comprising a triazole antifungal compound |
07/31/2007 | CA2162530C Novel crystalline cephem acid addition salts and processes for their preparation |
07/31/2007 | CA2077763C Use of leukaemia inhibitory factor for regulating neuron development and maintenance |
07/26/2007 | WO2007084073A1 Novel compounds and use thereof |
07/26/2007 | WO2007083807A1 Peptide derived from hepatitis c virus |
07/26/2007 | WO2007083806A1 HEPATITIS C VIRUS 2a-DERIVED HLA-A2-RESTRICTED ANTIGEN PEPTIDE |
07/26/2007 | WO2007083123A1 Use of elderberry extract |
07/26/2007 | WO2007082922A2 Long term treatment of hiv- infection with tcm278 |
07/26/2007 | WO2007082910A1 Dicarbonylic compounds with antibacterial activity |
07/26/2007 | WO2007082554A1 Modulators of hcv replication |
07/26/2007 | WO2007082547A1 Eye tuberculosis treating agent and method for the production and use thereof |
07/26/2007 | WO2007082425A1 A chinese medicine composition and its process and use |
07/26/2007 | WO2007082416A1 Traditional chinese medical compositions for treating avian influenza, processes for preparation and usage thereof |
07/26/2007 | WO2007065231A3 Azacytosine derivatives useful as antiviral agents |
07/26/2007 | WO2007065007A3 Treatment of viral infections |
07/26/2007 | WO2007064993A3 Bicyclic protein kinase inhibitors |
07/26/2007 | WO2007059421A3 Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same |
07/26/2007 | WO2007017762A3 Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections |
07/26/2007 | US20070173502 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
07/26/2007 | US20070172927 Immune complexes comprising proteins of human immunodeficiency virus type 2 (HIV-2), antibodies against proteins of HIV-2, methods and kits employing proteins of HIV-2, and immunogenic compositions comprising proteins of HIV-2 |
07/26/2007 | US20070172877 Methods for preventing cattle reproductive diseases |
07/26/2007 | US20070172547 Antibacterial compositions |
07/26/2007 | US20070172532 Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2 |
07/26/2007 | US20070172516 Increasing of the resorption of substances via skin and mucous membranes |
07/26/2007 | US20070172512 administering Lactobacillus paracasei that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier; liver cirrhosis |
07/26/2007 | US20070172499 Immunotherapy for humans |
07/26/2007 | US20070172494 Cold-adapted equine influenza viruses |
07/26/2007 | US20070172489 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza |
07/26/2007 | US20070172458 IL-6/IL-6R fusion protein |
07/26/2007 | US20070172450 Modulation of immune response and methods based thereon |
07/26/2007 | US20070172447 Agent for preventing and/or treating tissue disruption-accompanied diseases |
07/26/2007 | DE102006051941A1 Multifunctional active agent mixture, useful as auxiliary material in virus vaccine or vaccine to treat cancer, comprises fraction of specific peptide in polypetide chain and fraction with essential and non-essential amino acids |
07/26/2007 | DE102006003443A1 Asparagin-10-substituierte Nonadepsipeptide Asparagine-10-substituted nonadepsipeptides |
07/26/2007 | DE102006002816A1 Agent, useful for the therapy and prophylaxis of human immunodeficiency virus, and as a food supplement, comprises zeolite and further materials |
07/26/2007 | DE102005055944A1 Neue cyclische Iminopeptid-Derivate und ein Verfahren zur Herstellung von cyclischen Iminopeptid-Derivate Iminopeptid novel cyclic derivatives, and a process for the preparation of cyclic derivatives Iminopeptid |
07/26/2007 | CA2637417A1 Novel indoloquinoxaline derivatives and their use in the treatment of viral infections |
07/26/2007 | CA2637052A1 Dicarbonylic compounds with antibacterial activity |
07/26/2007 | CA2636916A1 Methods for treating hepatitis c |
07/26/2007 | CA2636905A1 Methods for treating hepatitis c |
07/26/2007 | CA2636436A1 Long term treatment of hiv- infection with tmc278 |
07/26/2007 | CA2632768A1 Use of elderberry extract |
07/25/2007 | EP1811024A1 Oligo double-stranded rna and medicinal composition |
07/25/2007 | EP1810694A2 Water-soluble compositions of bioactive lipophilic compounds |
07/25/2007 | EP1810691A2 Immunotherapy for reversing immune suppression |
07/25/2007 | EP1810672A1 Veterinary use of a pleuromutilin derivative against secondary pneumonia in swine |
07/25/2007 | EP1809657A1 Cyclic nonapeptide amides |
07/25/2007 | EP1809654A1 Heterocyclyl-substituted nonadepsipeptides |
07/25/2007 | EP1809653A1 Substituted nonadepsipeptides |
07/25/2007 | EP1809645A1 Antimicrobial 2-deoxystreptamine compounds |
07/25/2007 | EP1809639A2 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents |
07/25/2007 | EP1809380A2 Inhibitors of hiv-1 capsid formation: substituted aryl aminomethyl thiazole ureas and analogues thereof |
07/25/2007 | EP1809334A2 Conjugates with enhanced cell uptake activity |
07/25/2007 | EP1809300A1 Method for treating bacterial infections in horses or pigs with tilmicosin |
07/25/2007 | EP1809269A1 Sugars and/or sugar alcohols for inhibiting and/or treating vaginal infection |
07/25/2007 | EP1809252A2 Particles for treatment of pulmonary infection |
07/25/2007 | EP1809107A2 Compositions and methods of dispensing palliative or therapeutic agents |
07/25/2007 | EP1594978B1 Assay for the identification of protein sic inhibitors |
07/25/2007 | EP1581207A4 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
07/25/2007 | EP1556389B1 Cephem compounds |
07/25/2007 | EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
07/25/2007 | EP1444236B1 Separation of regioisomers of metal phthalocyanines |
07/25/2007 | EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents |
07/25/2007 | EP1370265B1 Hiv inhibiting pyrazinone derivatives |
07/25/2007 | EP1355873B1 Pleuromutilin derivatives with antimicrobial activity |
07/25/2007 | EP1351940B1 Substituted quinolines for the treatment of protozoan and retrovirus co-infections |
07/25/2007 | EP1282610B1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
07/25/2007 | EP1200594B1 Protective antigen of epstein barr virus |
07/25/2007 | EP1189622B1 Anionic polymers as toxin binders and antibacterial agents |
07/25/2007 | EP1143985B1 Use of lactobacillus salivarius |
07/25/2007 | EP1143933B1 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
07/25/2007 | EP1032592B1 Antimicrobial peptides |
07/25/2007 | EP0824546B1 Angiostatin fragments and methods of use |
07/25/2007 | EP0820281B1 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses |
07/25/2007 | CN1328373C Porcine circus-virus 2 type recombinant adenovirus and vaccine |
07/25/2007 | CN1328286C Aglyco products and method of use |
07/25/2007 | CN1328285C Inhibitor of stem cell proliferation and uses thereof |
07/25/2007 | CN1328279C Viral inhibitors |
07/25/2007 | CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
07/25/2007 | CN1327900C Attenuated typhoid bacillus vaccine of virus gene carried on chromosome and its preparation method |
07/25/2007 | CN1327896C Compositions and method for treating viral infections |
07/25/2007 | CN1327895C Method for preparing aftosa vaccine |
07/25/2007 | CN1327894C Nucleic acid encoding hyaluronan synthase and method of use |
07/25/2007 | CN1327870C Exterior-applied medicine for treating dermatopathy |
07/25/2007 | CN1327861C Composition for preventing SARS and homologous SARS syndrome |
07/25/2007 | CN1327859C Schisandra fruit extractive, its preparation process and purposes |
07/25/2007 | CN1327839C Matrine capsule and its preparation method |
07/25/2007 | CN1327837C Medicine of total coumarins from dried fruits for treating allergic skin disease |
07/25/2007 | CN1327835C Hepedestal oral disintegration tablet and its preparing method |
07/25/2007 | CN1327831C Method for preparing drug material of swertiamarin |
07/25/2007 | CN1327829C Sustained release preparation of root of indian stringbush |
07/25/2007 | CN101006172A Anticancer agent containing dendritic cell having RNA virus transferred thereinto |
07/25/2007 | CN101006171A Anticancer agent containing minus-strand RNA virus |